AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
IMATINIB in Zimbabwe
1 product registered with MCAZ — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| IMATIS 100 MG TABLET; ORAL | 2017/9.4/5346 | KEY ONCOLOGICS (PYT) LTD | active | 31 Dec 2027 |
IMATINIB — MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing IMATINIB, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track IMATINIB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.